Among patients with bowel cancer, nearly half of the cases can be prevented by lifestyle changes.
Of the 42,000 people diagnosed each year, 95% are over 50 years old. Risk factors include overweight, smoking, alcoholism, and type 2 diabetes. Here are our recommendations that can help you reduce the probability of bowel cancer.
Not to reduce carbohydrate intake
Carbohydrates help speed up the flow of food in your body. It is best to stick to whole-wheat varieties:brown bread, rice and pasta or whole-wheat semolina or quinoa.These foods are also anti-inflammatory effects, it can help your gut,but also vitamin E important sources.
Eat more fruits and vegetables
Fruits and vegetables are essential for a healthy diet, especially because they are another major source of fiber. Studies have shown that ingesting large amounts of vitamin C can help reduce the risk of bowel cancer. Therefore,storage of oranges and other citrus fruits, plus peppers, berries and kiwi are necessary.
Limit in take of processed meat
Charity Beating Bowel Cancer, said the disease with diet contains large amounts of red meat and processed meats have close ties.The agency recommends eating less than 500 grams of red meat per week. Processed meats such as bacon, ham and salami, and you will face a greater risk of colorectal cancer the risk.
Fish
Another option for meat is fish, especially oily varieties like salmon, mackerel, anchovy and sardines. 2016 King’s College London study shows that eating a few mouthfuls of oil per dayoffish can significantly reduce the risk of colorectal cancer. Because these types of fish are rich in omega 3 fatty acids and have anti-inflammatory properties. In addition, they also contain a lot of vitamin D, which also helps to control cancer.
Reduce alcohol intake
Reducing alcohol in take is a clear and simple prevention of colorectal cancer in the method. Don’t panic-you don’t need to give up completely. It may be less a drink or choose to drink point of alcohol lower content of beverages.
Susan Hau is a distinguished researcher in the field of cancer cell therapy, with a particular focus on T cell-based approaches and cancer vaccines. Her work spans several innovative treatment modalities, including CAR T-cell therapy, TIL (Tumor-Infiltrating Lymphocyte) therapy, and NK (Natural Killer) cell therapy.
Hau's expertise lies in cancer cell biology, where she has made significant contributions to understanding the complex interactions between immune cells and tumors.
Her research aims to enhance the efficacy of immunotherapies by manipulating the tumor microenvironment and exploring novel ways to activate and direct immune responses against cancer cells.
Throughout her career, Hau has collaborated with leading professors and researchers in the field of cancer treatment, both in the United States and China.
These international experiences have broadened her perspective and contributed to her innovative approach to cancer therapy development.
Hau's work is particularly focused on addressing the challenges of treating advanced and metastatic cancers. She has been involved in clinical trials evaluating the safety and efficacy of various immunotherapy approaches, including the promising Gamma Delta T cell therapy.
- Susan Hauhttps://cancerfax.com/author/susan/
- Susan Hauhttps://cancerfax.com/author/susan/
- Susan Hauhttps://cancerfax.com/author/susan/
- Susan Hauhttps://cancerfax.com/author/susan/